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 Abstract  This is a short summary of my presentation in the Uehara Memorial 
Foundation Symposium 2014. Classiﬁ cation of mental illness in current diagnostic 
systems [such as the  Diagnostic and Statistical Manual of Mental Disorders (DSM)] 
is built on clinical reliability and utility, but not on etiological validity. Thus, the 
DSM has not provided an ideal classiﬁ cation of mental disorders. To overcome the 
dilemma, the National Institute of Mental Health (NIMH) recently proposed the 
Research Domain Criteria (RDoC) framework. This new framework emphasizes a 
dimensional approach on the basis of neurocircuitry mechanism. There were three 
aims in my presentation. First, I summarized the concept of research strategies on 
the basis of dimensional approach, with a link to the trajectory from early develop-
ment to adolescence in the disease pathology. Second, I introduced an example of a 
research infrastructure that could support translational and clinical study for mental 
illness. Third, I showed two studies that were utilizing the infrastructure. 
 Keywords  Mental disorders •  Diagnostic and statistical manual of mental disor-
ders (DSM) •  Research domain criteria (RDoC) •  Dimensional approach • 
 Developmental trajectory •  Translational research 
 Introduction 
 The Uehara Memorial Foundation Symposium 2014 was held on June 15, 16, and 
17 in Tokyo, under the theme of Innovative Medicine—Basic Research and 
Development. The role of my presentation was to provide information on the front-
line of clinical and translational research in psychiatry to the audience. 
 Although psychiatry is obviously a domain of modern medicine, studying brain 
disorders, the classic problem of the brain–mind discontinuity has slowed down 
scientiﬁ c progress in psychiatry. Consequently, many different disciplines have 
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competed with each other in psychiatry in the past century. Such factionalism was 
also a major obstacle to the development of psychiatry as a key domain of modern 
medicine. Finally, as a major collaborative effort among psychiatrists, a comprehen-
sive diagnostic manual that standardizes the classiﬁ cation of psychiatric disorders 
was issued as the  Diagnostic and Statistical Manual of Mental Disorders (DSM) 
third edition in 1980. The DSM has been useful in standardizing clinical practice in 
psychiatry with high reliability. However, the DSM has been formulated under 
ignorance of (or minimal attention to) the etiological and biological validity in its 
disease classiﬁ cation. Thus, this nature of the DSM has been a major deﬁ cit in 
building research on the basis of disease classiﬁ cation deﬁ ned by this manual. 
 To overcome this dilemma, the National Institute of Mental Health (NIMH) 
included in its new strategic plan the following aim: “develop, for research pur-
poses, new ways of classifying mental disorders based on dimensions of observable 
behavior and neurobiological measures” [ 1 ]. According to the Cuthbert article, “the 
implementation of this aim was named the Research Domain Criteria project or 
RDoC.” The RDoC is formulated in a matrix: it has multiple dimensions that cut 
across traditional diagnostic categories, such as attention and perception. Meanwhile, 
biological correlates for each dimension are considered at multiple levels, such as 
the molecular, cellular, circuitry, and behavioral levels. 
 There is another important viewpoint to develop research for mental illness. This 
is the viewpoint of the developmental trajectory. Many mental disorders, such as 
schizophrenia and psychotic disorders, mood disorders, and substance use disor-
ders, appear in young adulthood, and epidemiological and clinical studies have indi-
cated that major risks for such disorders occur in developmental stages. Thus, it is 
very important to study the mechanisms of how disease-associated risk factors at 
earlier ages are accumulated and result in the onset of the disease in the develop-
mental trajectory. The NIMH has also stated that dimensional approaches such as 
the RDoC may be used in conjunction with attention to neurodevelopment and 
disease- associated environmental factors. 
 Thus, the aim of my presentation in the symposium was to introduce these two 
elements essential to research for mental disorders (e.g., a dimensional approach 
and attention to the neurodevelopmental trajectory in disease pathology), and then 
to present a representative infrastructure of translational and clinical research on the 
based on these two elements. 
 Major Mental Illness Caused by a Combination of Multiple 
Genetic Risk Factors and Environmental Stressors 
in the Pathological Trajectory 
 The majority of mental disorders are caused by a combination of multiple genetic 
risk factors and environmental stressors (Fig.  1 ). The combination is not random but 
is likely to result in certain numbers of common biological pathways. It is possible 
that these pathways underlie clinical manifestations, which are organized in a 
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dimensional way. If we take schizophrenia (SZ) and related psychotic conditions, 
the risk factors and stressors are likely to contribute to the pathology in early devel-
opment and adolescence (Fig.  2 ). Nonetheless, the onset of the disease is in late 
adolescence and young adulthood. Thus, it is crucial to study the disease mecha-
nisms in the developmental trajectory. In many medical diseases, the signiﬁ cance of 
early detection and early intervention has been highlighted. Accordingly, in the case 
of SZ, studying the transition from risk stages to the onset (the prodromal stage) is 
regarded as one of the most important research topics at present. Given that current 
medications for psychosis target only symptomatic aspects and are limited in their 
efﬁ cacy, many investigators optimistically expect that the study of the prodromal 
stage may identify novel therapeutic targets that are associated with the disease 
progression and overcome the current limitations (Fig.  2 ). In regard to the mecha-
nisms associated with the disease progression in the prodromal stage, it is possible 
that aberrant activation of stress-related cascades underlie disturbed postnatal brain 
maturation, which results in brain dysfunction and manifestation of mental symp-
toms (Fig.  3 ) [ 2 ,  3 ].
 Research Infrastructure That Allows a Multifaceted 
Translational Approach to Major Mental Illness 
 After the introduction of the dimensional approach in the developmental trajectory, 
particularly in the context of SZ and psychotic conditions, I presented an example 
of a research infrastructure that supports translational and clinical study for mental 
 Fig. 1  From etiologies to clinical manifestations: the majority of mental disorders are caused by 
a combination of multiple genetic risk factors and environmental stressors 
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 Fig. 2  Developmental trajectory of schizophrenia and related psychotic conditions. Although the 
onset of SZ is in young adulthood, epidemiological studies have suggested that many environmen-
tal risk insults for SZ occur during early development and adolescence ( asterisks ). Biological 
studies have also provided evidence that roles for genetic risk factors are associated with neurode-
velopment (Adopted and modiﬁ ed from Jaaro-Peled et al. [ 2 ]) 
 Fig. 3  Gene environmental interactions that underlie disturbed postnatal brain maturation, brain 
dysfunction, and mental disorders. Genetic and environmental factors for SZ are likely to converge 





disorders (Fig.  4 ). In this infrastructure, whenever study subjects (patients and 
matched controls) are enrolled, they are assessed clinically and neuropsychologi-
cally. They also participate in brain imaging studies, including positron emission 
tomography (PET) and magnetic resonance imaging (MRI), which are essential to 
address brain circuitry disturbance directly in vivo. In parallel, the study partici-
pants donate their tissues in multiple ways, including blood draw, skin biopsy, and 
nasal biopsy. We can obtain an olfactory epithelium (OE) sample easily by nasal 
biopsy. OE includes neuroprogenitor cells, immature neurons, and mature neurons: 
thus, by studying OE-derived cells and tissues, we can examine molecular and cel-
lular signatures relevant to neuronal cells (Fig.  5 ) [ 4 ]. The information from the 
cells and tissues can be correlated with the brain imaging characteristics and clinical 
manifestations from the same subjects. As described above, RDoC-oriented studies 
are expected to study biological correlates and clinical manifestations at multiple 
levels, such as the molecular, cellular, circuitry, and behavioral levels. Thus, this 
infrastructure can meet such expectations. The disease trajectory may be addressed 
by designing a longitudinal study in this infrastructure.
 Two Representative Studies that Use the Research 
Infrastructure 
 We previously reported that a speciﬁ c phosphorylation of DISC1 (serine residue at 
the 710th amino acid of mouse DISC1) has a crucial role in the switch of cell fate 
from neuroprogenitor proliferation to postmitotic differentiation [ 5 ]. DISC1 has 
 Fig. 4  An example of research infrastructure that supports translational and clinical study for 
mental disorders. In this infrastructure, whenever study subjects (patients and matched controls) 
are enrolled, they are assessed clinically and neuropsychologically. They also participate in brain 
imaging studies as well as tissue biopsies. Taken together, according to the ethical guideline, inves-
tigators can build multifaceted translational study on this research platform 
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been involved as a biological hub protein for multiple pathways associated with 
mental illnesses [ 6 ]. It remains elusive how this phosphorylation (serine residue at 
the 713th amino acid of human DISC1) underlies cellular, circuitry, and behavioral 




















 Fig. 5  Olfactory biopsy as a effective approach to obtain biospecimens with neuronal molecular 
signature. An olfactory epithelium (OE) sample, which is easily obtained by nasal biopsy, includes 
neuroprogenitor cells, immature neurons, and mature neurons; thus, by studying OE-derived cells 
and tissues, we can examine molecular and cellular signatures relevant to neuronal cells (Adopted 
from Sawa and Cascella [ 4 ]) 
 Fig. 6  A speciﬁ c phosphorylation of DISC1 controls cell fate from neuroprogenitor proliferation 
to postmitotic neuronal differentiation: an entry point for translational study of mental illness. 
DISC1 has been involved as a biological hub protein for multiple pathways associated with mental 
illnesses. Phosphorylation of DISC1 at one speciﬁ c amino acid residue is known to be crucial for 
neurodevelopment in mice. However, it remains elusive how this phosphorylation (serine residue 
at 713th amino acid of human DISC1) underlies cellular, circuitry, and behavioral manifestations 
associated with mental disorders. The infrastructure introduced in Fig.  4 , including the utilization 





preliminary data that studied the phosphorylation in olfactory cells from patients 
and controls, in correlation with their brain imaging characteristics and clinical traits.
 In addition, I also presented studies in which the molecular signature of the cere-
brospinal ﬂ uid was examined from patients in the prodromal stage and with the ﬁ rst 
episode of psychosis, in comparison with matched controls. In the ﬁ rst set of publi-
cations from the study, we observed robust changes in the molecules associated with 
immune and inﬂ ammatory responses, as well as oxidative stress [ 7 ,  8 ]. I also intro-
duced a perspective of how we can study such molecular information in correlation 
with brain imaging characteristics and clinical manifestations. 
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